.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 6,756,053

« Back to Dashboard

Details for Patent: 6,756,053

Title: Controlled heat induced rapid delivery of pharmaceuticals from skin depot
Abstract:The present invention is directed to a method and system for delivering a drug into the systemic circulation. The method comprises establishing a drug depot in a patient's skin and/or sub-skin tissues by applying a transdermal drug delivery system on the patients skin, for a predetermined time so that a drug depot is formed in said user's skin and/or sub-skin tissues. A heating source is placed proximate to the skin area to rapidly release a bolus of the drug from the depot into the systemic circulation when there is a need to rapidly increase the drug's concentrations in the systemic circulation.
Inventor(s): Zhang; Jie (Salt Lake City, UT), Hull; Wade (Taylorsville, UT), Rigby; Larry (Salt Lake City, UT)
Assignee: Zars, Inc. (Salt Lake City, UT)
Filing Date:Jun 11, 2001
Application Number:09/878,558
Claims:1. A method of delivering a drug into a user's systemic circulation, comprising: establishing a drug depot in tissues under the user's skin surface by applying a transdermal drug delivery system on a user's skin; allowing said transdermal drug delivery system to be applied on said skin area without heating for at least a predetermined depot accumulation time so that a drug depot is formed in tissues under the surface of said skin area; and placing a controlled heating source with a predetermined safe heating duration proximate to said skin area to deliver a predetermined safe dosage of the drug from the depot site into the systemic circulation.

2. The method of claim 1, wherein said drug is capable of providing a clinical benefit to a user if said drug's concentrations in said user's systemic circulation can be rapidly increased when a clinical need arises.

3. The method of claim 1, wherein said drug is capable of providing certain clinical benefit to a user when said drug's concentrations in said user's systemic circulation are maintained at pre-determined levels for an extended period of time, and is capable of providing added clinical benefit to said user if its concentrations in said user's systemic circulation can be rapidly increased on demand.

4. The method of claim 1, wherein said drug is an analgesic.

5. The method of claim 1, wherein said drug is fentanyl.

6. The method of claim 1, wherein said drug is sufentanil.

7. The method of claim 1, wherein said pe-determined depot accumulation time is about 30 minutes.

8. The method of claim 1, wherein said pre-determined depot accumulation time is at least about one minute.

9. The method of claim 1, wherein said pre-determined depot accumulation time is longer than at least 60 minutes.

10. The method of claim 1, wherein said pre-determined depot accumulation time is about 60 minutes.

11. The method of claim 1, wherein said heating source is capable of heating for a predetermined duration.

12. The method of claim 1, wherein said heating source is capable of heating for a predetermined duration between about 5 seconds and 60 minutes.

13. The method of claim 1, wherein said heating source is capable of heating for a predetermined duration between about 10 seconds to 30 minutes.

14. The method of claim 1, wherein said heating source is capable of heating said skin area to a predetermined temperature range for longer than 60 minutes.

15. The method of claim 1, wherein said heating source is capable of heating said skin area to a predetermined temperature range for a predetermined duration of between about 5 seconds to 60 minutes.

16. The method of claim 15, wherein said predetermined temperature range is between about 39-43 C.

17. The method of claim 15, wherein said predetermined temperature range is between about 39-43 C.

18. A method to provide baseline concentrations of an analgesic in a human being's systemic circulation and to rapidly deliver a bolus dose of said analgesic into said systemic circulation when said human being is suffering from an increased level of pain, comprising: applying a transdermal analgesic delivery system onto a skin area of a human being to establish baseline concentrations of said analgesic in said human being's blood; allowing said transdermal analgesic delivery system to be applied without heating for a time sufficient to allow the formation of an analgesic depot in tissues under the surface of said skin area of said human being; and placing a heating source proximate to said skin area when said human being suffers from increased level of pain.

19. A method of delivering a drug into the systemic circulation of a human being, comprising: establishing a drug depot in tissues under the surface of a skin area by applying a transdermal drug delivery system on the skin area of a human being and heating said skin area to a first temperature range for a predetermined depot accumulation time; allowing said transdermal drug delivery system to be applied while heating said skin area to said first temperature range for a predetermined depot accumulation time; and heating said skin area to a second temperature range, which is higher than said first temperature range, for a second pre-determined period of time.

20. A method to provide baseline concentrations of fentanyl in a human being's systemic circulation and to rapidly deliver a bolus dose of fentanyl into said systemic circulation when said human being is suffering from an increased level of pain, comprising: applying a transdermal fentanyl delivery system onto a skin area of a human being to establish baseline concentrations of fentanyl in said human being's blood; allowing said transdermal fentanyl delivery system to be applied without heating for a time sufficient to allow the formation of a fentanyl depot in tissues under the surface of said skin area of the said human being; and placing a heating source proximate to said skin area when said human being suffers from increased level of pain.

21. A method to provide baseline concentrations of sufentanil in a human being's systemic circulation and to rapidly deliver a bolus dose of sufentanil into said systemic circulation when said human being is suffering from an increased level of pain, comprising: applying a transdermal sufentanil delivery system onto a skin area of a human being to establish baseline concentrations of sufentanil in said human being's blood allowing said transdermal sufentanil delivery system to be applied without heating for a time sufficient to allow the formation of a sufentanil depot in tissues under the surface of said skin area of the said human being; and placing a heating source proximate to said skin area when said human being suffers from increased level of pain.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc